Live From Sohn: Valeant is Just Like Berkshire Hathaway, Bill Ackman Says

Bill Ackman used his 15 minutes at the Ira Sohn investment conference Monday to further explain his investment in pharmaceutical company Valeant Pharmaceuticals (VRX), and why he thinks Wall Street has continually undervalued companies like it. Ackman says he started buying the stock at $161, and it’s now at $223. He thinks it could rise another [...]